DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,333,041,688 | +104.8% | 5,373,002 | +98.1% | 0.27% | +104.6% |
| Q2 2023 | $650,968,415 | -30.0% | 2,712,368 | -26.5% | 0.13% | -33.8% |
| Q1 2023 | $930,038,833 | -0.1% | 3,690,044 | +5.2% | 0.20% | -4.8% |
| Q4 2022 | $931,275,790 | -11.8% | 3,508,688 | -14.2% | 0.21% | -14.8% |
| Q3 2022 | $1,055,943,000 | +16.8% | 4,088,205 | +14.6% | 0.24% | +19.6% |
| Q2 2022 | $904,377,000 | -4.2% | 3,567,284 | +10.9% | 0.20% | +2.5% |
| Q1 2022 | $943,641,000 | -7.9% | 3,216,991 | +3.3% | 0.20% | -2.5% |
| Q4 2021 | $1,024,446,000 | +9.8% | 3,113,721 | +1.6% | 0.20% | +3.0% |
| Q3 2021 | $932,636,000 | +6.5% | 3,063,446 | -6.1% | 0.20% | +1.0% |
| Q2 2021 | $875,773,000 | +12.2% | 3,263,429 | -5.9% | 0.20% | 0.0% |
| Q1 2021 | $780,615,000 | +22.4% | 3,468,164 | +20.8% | 0.20% | +19.5% |
| Q4 2020 | $637,894,000 | +23.5% | 2,871,586 | +19.7% | 0.16% | +11.6% |
| Q3 2020 | $516,600,000 | -3.1% | 2,399,105 | -20.4% | 0.15% | -9.3% |
| Q2 2020 | $533,196,000 | +5.0% | 3,015,291 | -17.8% | 0.16% | -10.0% |
| Q1 2020 | $507,664,000 | -37.5% | 3,667,837 | -30.7% | 0.18% | -13.0% |
| Q4 2019 | $812,866,000 | +34.5% | 5,296,233 | +26.5% | 0.21% | +19.0% |
| Q3 2019 | $604,497,000 | +5.6% | 4,185,392 | +4.5% | 0.17% | +6.1% |
| Q2 2019 | $572,395,000 | +6.1% | 4,005,007 | -2.0% | 0.16% | +0.6% |
| Q1 2019 | $539,492,000 | +25.0% | 4,086,441 | -2.4% | 0.16% | +18.1% |
| Q4 2018 | $431,666,000 | -7.2% | 4,186,042 | -2.2% | 0.14% | +16.0% |
| Q3 2018 | $465,264,000 | +0.8% | 4,281,838 | -8.5% | 0.12% | -4.8% |
| Q2 2018 | $461,568,000 | -27.6% | 4,677,429 | -28.2% | 0.12% | -23.3% |
| Q1 2018 | $637,438,000 | +12.0% | 6,510,445 | +6.1% | 0.16% | +19.9% |
| Q4 2017 | $569,311,000 | +30.3% | 6,133,503 | +20.5% | 0.14% | +27.1% |
| Q3 2017 | $436,788,000 | -0.2% | 5,091,949 | -1.8% | 0.11% | -5.3% |
| Q2 2017 | $437,717,000 | +4.9% | 5,186,828 | +6.4% | 0.11% | 0.0% |
| Q1 2017 | $417,075,000 | +14.1% | 4,876,373 | +3.9% | 0.11% | +8.7% |
| Q4 2016 | $365,431,000 | +62.7% | 4,694,630 | +63.8% | 0.10% | +55.2% |
| Q3 2016 | $224,605,000 | -4.1% | 2,865,225 | +23.6% | 0.07% | -13.0% |
| Q2 2016 | $234,187,000 | -1.7% | 2,318,688 | -7.7% | 0.08% | -1.3% |
| Q1 2016 | $238,244,000 | -17.5% | 2,511,532 | -19.2% | 0.08% | -14.3% |
| Q4 2015 | $288,653,000 | -25.4% | 3,107,802 | -31.6% | 0.09% | -30.5% |
| Q3 2015 | $387,144,000 | -13.5% | 4,543,420 | -13.2% | 0.13% | -5.8% |
| Q2 2015 | $447,823,000 | -12.6% | 5,232,203 | -13.3% | 0.14% | -15.2% |
| Q1 2015 | $512,463,000 | +52.2% | 6,036,071 | +53.6% | 0.16% | +54.7% |
| Q4 2014 | $336,789,000 | -5.3% | 3,929,394 | -16.0% | 0.11% | -5.4% |
| Q3 2014 | $355,485,000 | -18.3% | 4,678,652 | -15.3% | 0.11% | -17.6% |
| Q2 2014 | $434,967,000 | -24.6% | 5,524,792 | -28.1% | 0.14% | -28.0% |
| Q1 2014 | $576,556,000 | +9.0% | 7,687,394 | +12.2% | 0.19% | +8.6% |
| Q4 2013 | $529,048,000 | +23.6% | 6,852,936 | +11.0% | 0.17% | +9.4% |
| Q3 2013 | $427,954,000 | +19.2% | 6,173,617 | +8.9% | 0.16% | +14.4% |
| Q2 2013 | $358,896,000 | +55.5% | 5,669,753 | +37.3% | 0.14% | +44.8% |
| Q4 2012 | $230,773,000 | +29.5% | 4,128,304 | +27.8% | 0.10% | +35.2% |
| Q3 2012 | $178,214,000 | +34.5% | 3,231,420 | +27.0% | 0.07% | +20.3% |
| Q2 2012 | $132,546,000 | -9.4% | 2,545,051 | -2.6% | 0.06% | -14.5% |
| Q1 2012 | $146,264,000 | – | 2,611,861 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |